课题基金 / 基金详情

Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use

Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
通过烟酒联合治疗降低癌症风险
批准号:
8134407
负责人:
ELBA C DIAZ-TORO
金额:
$18.57万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

ELBA C DIAZ-TORO的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 烟草是#年可预防的死亡和残疾的首要原因,酒精是第三大主要原因。 在美国,几乎三分之一的癌症直接可归因于吸烟,而酒精会增加患癌症的风险 口腔癌、咽癌、喉癌、食道癌、肝癌、结肠癌、直肠癌和乳腺癌。此外,伴随而来的是 吸烟和饮酒协同作用增加了患某些癌症(如头部和颈部)的风险。不仅 吸烟和饮酒本身就是重大的公共卫生问题,它们是密切相关的行为。 吸烟者比不吸烟者更有可能饮酒,而且问题饮酒的流行率要高得多 吸烟者高于不吸烟者。 不幸的是,吸烟和酗酒是波多黎各的主要公共卫生问题。尽管 居住在PR的波多黎各人的吸烟率(12.5%)低于美国大陆(20.6%), PR的五大主要死亡原因与吸烟有关(即心脏病、癌症、中风、 高血压和慢性肺部疾病)。同样,尽管波多黎各人饮酒的可能性比现在低 无论是美国的普通人口还是美国的拉美裔美国人,如果 他们确实喝酒(http://www.cdc.gov/brfss/).此外,酒精和酒精对健康的负面影响 烟草并不严格限于大量或滥用。例如,每种与酒精有关的风险 男性每天饮酒超过两杯,而每天饮酒一杯,巨蟹座的人数会大幅增加。 女性每天喝一杯。事实上,来自医学研究所(IOM)的一份里程碑式的报告指出, 饮酒(慢性中到重度饮酒、酗酒或酒后驾车)被视为严重的公众 健康问题,因为它还与许多其他负面健康和社会后果有关 就像癌症一样。因此,国际移民组织建议将高危人群的筛查、预防和治疗结合起来。 在公共卫生环境中饮酒。因此,波多黎各人降低癌症风险的关键战略 吸烟者正在减少这两种物质的使用。 这项拟议的研究是一项随机临床试验,将评估一种独特的、理论上和 基于经验的“动机和问题解决”(MAP)方法,用于治疗烟草和有风险的酒精 在以人口为基础的公共卫生环境中使用。MAPS是一种处理方法,它结合了 激励性访谈和认知行为/解决问题的治疗方法。参与者为 波多黎各吸烟者,他们也是饮酒者,他们打电话给波多黎各Quitline(PRO)吸烟者 戒烟咨询。根据国家酒精滥用和酒精中毒研究所的定义,饮酒有风险, 指的是一系列增加身体和心理社会问题风险的饮酒行为。 我们之前对呼吁戒烟的吸烟者进行的研究表明,36%的吸烟者是有风险的饮酒者。 参与者(N=200)将被随机分配到以吸烟为重点的MAP治疗中 戒烟,或MAP+条件,重点是戒烟和减少有风险的酒精使用。 治疗是以电话为基础的,设计成很容易传播到医疗保健系统和其他 以人口为基础的烟酒控制环境。主要的结果变量是饮酒的风险。我们 假设MAP+将减少与MAP相关的酒精使用行为的风险。虽然我们也会 将戒烟作为一种结果进行检查,我们认为MAP和MAP之间没有区别 关于戒烟结果的MAP+。尽管ML和认知行为/问题解决 在酒精使用和戒烟的治疗方面,方法有相对较长的历史,最好的是 根据我们的知识,这项研究将是第一次将激励增强的方法应用于同时 治疗吸烟和酗酒。需要注意的是,MAPS+的目标不一定是为了促进 戒酒,但要改变有风险的饮酒行为。 该项目的具体目标是: 1.评估地图和地图+对波多黎各高危饮酒(和戒烟)的影响 Rican吸烟者,也是有风险的饮酒者。 2.评估MAP和MAP+对治疗机制的影响以及这些机制在 调解高危饮酒(和戒烟)的治疗效果。 3.评估MAP和MAP+在减少高危饮酒(和吸烟)方面的成本效益 停止)。
英文摘要
ABSTRACT Tobacco is the leading cause and alcohol is the third leading cause of preventable death and disability in the U.S. Almost one-third of all cancers are directly attributable to smoking, and alcohol increases the risk for cancers of the mouth, pharynx, larynx, esophagus, liver, colon, rectum, and breast. Moreover, the concomitant use of tobacco and alcohol synergistically increases the risk for some cancers (e.g., head and neck). Not only are tobacco and alcohol use major public health problems in their own right, they are closely linked behaviors. Smokers are much more likely to drink than are non-smokers and the prevalence of problem drinking is much higher among smokers than among nonsmokers. Unfortunately, tobacco and alcohol use are major public health problems in Puerto Rico (PR). Although the prevalence of smoking among Puerto Ricans living in PR is lower (12.5%) than in the continental U.S. (20.6%), the five leading causes of death in PR are associated with smoking (i.e., heart disease, cancer, stroke, hypertension and chronic pulmonary disease). Similarly, although Puerto Ricans are less likely to drink than is either the general population of the U.S. or Hispanics in the U.S., they are more likely to be binge drinkers if they do drink (http://www.cdc.gov/brfss/). Furthermore, the negative health consequences of alcohol and tobacco are not confined strictly to heavy or abusive use. For example, the risk for each of the alcohol-related cancers increases substantially with alcohol consumption of more than two drinks per day for men, and one drink per day for women. In fact, a landmark report from the Institute of Medicine (IOM) identified "at risk" drinking (chronic moderate to heavy levels of use, binge drinking, or drinking and driving) as a serious public health concern because it is associated with numerous other negative health and social consequences, as well as cancer. Therefore, the IOM recommended integrating screening, prevention, and treatment of at risk drinking into public health settings. Thus, a critical strategy for cancer risk reduction among Puerto Rican smokers is reducing the use of these two substances. The proposed study is a randomized clinical trial that will evaluate the efficacy of a unique, theoretically- and empirically-based "Motivation and Problem-Solving" (MAPS) approach to treating tobacco and at risk alcohol use in a population-based, public health setting. MAPS is a treatment approach that combines attributes of both motivational interviewing and cognitive behavioral/problem-solving treatment approaches. Participants are Puerto Rican smokers who are also "at risk" drinkers, and who call the Puerto Rico Quitline (PRO) for smoking cessation counseling. At risk drinking, as defined by the National Institute on Alcohol Abuse and Alcoholism, refers to a constellation of alcohol use behaviors that increase risk for physical and psychosocial problems. Our previous research among smokers calling the PRO indicates that 36% are at risk drinkers. Participants (N=200) will be randomly assigned to either a MAPS treatment with a focus on smoking cessation, or a MAPS+ condition that focuses on smoking cessation and the reduction of at risk alcohol use. Treatment is telephone-based, and designed to be easily disseminated to health care systems and other population-based settings for tobacco and alcohol control. The primary outcome variable is at risk drinking. We hypothesize that MAPS+ will reduce at risk alcohol use behaviors relative to MAPS. Although we will also examine smoking cessation as an outcome, we believe that there will be no difference between MAPS and MAPS+ with respect to smoking cessation outcomes. Although Ml and cognitive behavioral/problem-solving approaches have a relatively long history in the treatment of alcohol use and smoking cessation, to the best of our knowledge, this study would be the first to apply a motivational enhancement approach to concomitantly treating smoking and alcohol use. It is important to note that the goal of MAPS+ is not necessarily to promote abstinence from alcohol, but to modify at risk drinking behaviors. The specific aims of this project are to: 1. Evaluate MAPS and MAPS+ effects on at risk alcohol use (and smoking cessation) among Puerto Rican smokers who are also at risk drinkers. 2. Assess MAPS and MAPS+ effects on treatment mechanisms and the role of those mechanisms in mediating treatment effects on at risk drinking (and smoking cessation). 3. Evaluate the cost-effectiveness of MAPS and MAPS+ in the reduction of at risk drinking (and smoking cessation).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use
海外基金